bullish
JD Health: Looking Beyond the Obvious
413 Views01 Nov 2020 01:37
This Insight provides an in-depth view of JD Health in the context of a "penetration story" with a focus on the market opportunity to inform questions for management on the roadshow.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
Price Chart(Sign Up to Access)
- JOINN Laboratories - Q3 Performance in Line with Expectations; Promising Globalization After HK IPO15 Nov 2020
- JD Health (京东健康) Pre-IPO - Assumptions and Valuations13 Nov 2020
- JD Health (京东健康) Pre-IPO - Peer Comparison - It's a Close Fight and Competition Is Intensifying09 Nov 2020
- JD Health Pre-IPO: Poised to Benefit from Structural Changes in Healthcare in China and the Pandemic15 Oct 2020
- JD Health (京东健康) Pre-IPO - Well-Positioned to Ride China’s Healthcare Digitalization29 Sep 2020
- Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?25 Jun 2018
x